3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Nausea

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Nausea in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arseneau, JC; Blessing, JA; Homesley, HD; Thigpen, JT	1

Other Studies

1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Nausea

Article	Year
Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group study. American journal of clinical oncology, 1984, Volume: 7, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Piperazines; Thrombocytopenia; Uremia	1984

Article

Year

Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group study.

American journal of clinical oncology, 1984, Volume: 7, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Piperazines; Thrombocytopenia; Uremia

1984